Intismeran Autogene plus Pembrolizumab for Resected Stage IIB to IV Melanoma. (nejm.org)

Authors: Long GV … Del Vecchio M Journal: New England Journal of Medicine Published: 2026-11-11 DOI: https://doi.org/10.1056/NEJMoa2609762